Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other Working Capital Changes (2016 - 2025)

Surgery Partners' Other Working Capital Changes history spans 12 years, with the latest figure at -$27.7 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 194.68% year-over-year to -$27.7 million; the TTM value through Dec 2025 reached $56.6 million, up 20.94%, while the annual FY2025 figure was $56.6 million, 20.94% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$27.7 million at Surgery Partners, down from $2.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $61.7 million in Q1 2025 and bottomed at -$34.9 million in Q3 2023.
  • The 5-year median for Other Working Capital Changes is $7.0 million (2021), against an average of $11.5 million.
  • The largest annual shift saw Other Working Capital Changes plummeted 350.0% in 2022 before it skyrocketed 1757.69% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $41.3 million in 2021, then rose by 11.62% to $46.1 million in 2022, then decreased by 17.79% to $37.9 million in 2023, then plummeted by 124.8% to -$9.4 million in 2024, then plummeted by 194.68% to -$27.7 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Other Working Capital Changes are -$27.7 million (Q4 2025), $2.2 million (Q3 2025), and $20.4 million (Q2 2025).